Chris Shibutani

Chris Shibutani

#186 out of 1697 analysts
Goldman Sachs
Automatically Tracked
Tracking: 0 Updated: Jul 29 at 08:13 AM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
60.15%
Gain +1.28%
Monthly
1.86%
Yearly
24.77%
Drawdown
38.98%
$240,905.19
Equity
Holdings
$0
Cash
$240,905.19
Investment
$0
$140,646.99
Profit +$3,054.57
Realized
$140,646.99
Unrealized
$0
Dividends
$2,177.77
$240,905.19
Cash
Deposits
$100,258.2
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
1.28%
Profit
$3,054.57
Win %
100%
This Week
Compared To Last Week
Gain
8.98%
Profit
$19,854.71
Win %
100%
This Month
Compared to last month
Gain
11.46%
Profit
$24,768.58
Win %
100%
This Year
Compared to last year
Gain
4.61%
Profit
$10,622.55
Win %
40%
Seres Therapeutics, Inc. logo
MCRB Seres Therapeutics, Inc.
+$55,781.59
Nektar Therapeutics Inc. logo
NKTR Nektar Therapeutics Inc.
+$45,815.05
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
+$24,180.16
Syndax Pharmaceuticals Inc. logo
SNDX Syndax Pharmaceuticals Inc.
+$18,025.46
Neurocrine Biosciences Inc. logo
NBIX Neurocrine Biosciences Inc.
+$5,600.22
Amylyx Pharmaceuticals, Inc. Common Stock logo
AMLX Amylyx Pharmaceuticals, Inc. Common Stock
+$4,652.91
Vaxcyte, Inc. logo
PCVX Vaxcyte, Inc.
+$4,336.23
BioNTech SE logo
BNTX BioNTech SE
+$3,109.26
Alkermes plc logo
ALKS Alkermes plc
+$341.03
Royalty Pharma plc logo
RPRX Royalty Pharma plc
-$11,549.66
Erasca, Inc. logo
ERAS Erasca, Inc.
-$6,910.14
Kymera Therapeutics Inc. logo
KYMR Kymera Therapeutics Inc.
-$2,735.11
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
98
Longs Won
41/84 48%
Profit Factor
2.23
Profitability
Shorts Won
13/14 92%
Standard Deviation
$6,261.71
Average Win
$4,645.08
Best Trade
(Jan 19) $24,470.09
Sharpe Ratio
-61.26
Average Loss
-$2,553.75
Worst Trade
(Feb 14) -$10,688.42
Z-Score
-2.46 (100%)
Commissions
$0
Avg. Trade Length
2m 2d
Expectancy
$1,435.17
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% 0.01% 0.2% 2.06% 15.98%
Consecutive Losing Trades 94 85 75 66 57 47 38 28 19 9
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit (&#36;) Gain (%) Change
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV